anti-human MMP-9 monoclonal antibodies (State University of New York at Stony Brook)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-human MMP-9 monoclonal antibodies (State University of New York at Stony Brook)
Drug Alias Nameanti-human matrix metalloproteinase-9 monoclonal antibodies (State University of New York at Stony Brook)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesState University of New York at Stony Brook
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesState University of New York at Stony Brook
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A